Screener
Allogene Therapeutics ALLO EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Allogene Therapeutics’s 10-Q, filed August 12, 2026.
- Filed
- Aug 12, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-056213
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other income (expenses), net | (61) | (43) | 151 | 49 |
| Total other income (expenses), net | 4,243 | 5,876 | 7,728 | 11,334 |
| Net loss | (42,677) | (50,943) | (85,284) | (110,676) |
| Other comprehensive income (loss): | ||||
| Net unrealized gain (loss) on available-for-sale investments | (335) | (88) | (787) | 44 |
| Net comprehensive loss | $(43,012) | $(51,031) | $(86,071) | $(110,632) |
| Net loss per share, basic and diluted | $(0.13) | $(0.23) | $(0.30) | $(0.51) |
| Weighted-average number of shares used in computing net loss per share, basic and diluted | 328,930,269 | 218,929,548 | 284,855,386 | 217,153,948 |
Item 1. Financial Statements - Unaudited
FAQ
- What is Allogene Therapeutics's EPS (diluted)?
- Allogene Therapeutics (ALLO) reported EPS (diluted) of -$0.13 in Q2 2026.
- How has Allogene Therapeutics's EPS (diluted) changed year-over-year?
- Allogene Therapeutics's EPS (diluted) increased by 43.5% year-over-year, from -$0.23 to -$0.13.
- What is the long-term trend for Allogene Therapeutics's EPS (diluted)?
- Over 4 years (2021 to 2025), Allogene Therapeutics's EPS (diluted) has grown at a -10.4% compound annual growth rate (CAGR), from -$1.35 to -$0.87.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Allogene Therapeutics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude